Maternal #RSV vaccination and nirsevimab reduced RSV associated hospitalizations among US infants in 20242025 by up to 51%. Both interventions demonstrated high effectiveness and durability in real world surveillance. https: ja.ma 4saoasz With winter approaching, it's important to protect infants from RSV, which is very harmful to the very young. A safe and effective vaccine is available for pregnant women and newborns. Learn more: Un test simple et rapide pour savoir si vous avez des anticorps aprs le vaccin Le 18 septembre, l'Agence europenne du mdicament (EMA) a donn son feu vert la commercialisation d'Enflonsia (clesrovimab, MSD), un nouvel anticorps monoclonal destin la prvention des infections des voies respiratoires Anticorps monoclonaux